Dive into a deeper understanding of the role of inflammation in causing injury to the brain and spinal cord in multiple sclerosis. It's a journey marked by ups and downs, where the adaptive immune system composed of lymphocytes (T and B cells) attack myelin and the innate immune system clears damaged myelin. An immune cell called microglia can create smoldering inflammation in MS that poses a threat of progressive disability.

Explore the arsenal of MS treatment strategies developed over the past 3 decades to either alter or suppress the immune system to reduce inflammation. Triumphs and limitations of our current MS therapies shared. Antioxidant research, diet and new therapeutics tackling smoldering inflammation bring newfound hope.

Barry Singer MD, Director of The MS Center for Innovations in Care, interviews:

Klaus Schemierer MB BS, PhD, FRCP, Professor of Neurology at the Blizard Institute, Queen Mary University of London, and Consultant Neurologist at The Royal London Hospital, Barts Health NHS Trust.

Michael Kornberg MD, PhD, Assistant Professor of Neurology at John Hopkins.